British American Tobacco (BTI) and other cigarette companies were thwarted Monday when the US Supreme Court, without comment, declined to take up the company's appeal of a lower court decision siding with the US Food and Drug Administration and its plans requiring cigarette packaging and advertising to include larger and more explicit health warnings.
The FDA proposal would require the top half of cigarette packages to carry warnings about the health risks of smoking on both the front and back and would also expand the size of the warnings on the companies' print advertising. The rule was overturned on First Amendment grounds at the trial court level but reinstated by the US Court of Appeals' fifth circuit, which concluded the package warnings were "purely factual and uncontroversial" and thus fell within the agency's rule-making authority.
Rival cigarette-maker Altria Group (MO) had also signed on with an amicus filing supporting the British American legal challenge. The companies did not immediately respond to a request from MT Newswires seeking comment.
Price: 37.43, Change: +0.04, Percent Change: +0.12
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。